The Impact of Health Delivery Integration on Cancer Outcomes

Vishnukamal Golla; Deborah R Kaye

doi:10.1016/j.soc.2021.08.003

The Impact of Health Delivery Integration on Cancer Outcomes

Surg Oncol Clin N Am. 2022 Jan;31(1):91-108. doi: 10.1016/j.soc.2021.08.003.

Authors

Vishnukamal Golla¹, Deborah R Kaye²

Affiliations

¹ Duke National Clinician Scholars Program, 200 Morris St, Suite 3400, DUMC Box 104427, Durham, NC 27701, USA; Department of Surgery, Division of Urology, Duke University Medical Center, Durham, NC, USA; Duke Cancer Institute, Durham, NC, USA; Duke-Margolis Policy Center; Durham Veterans Affairs Health Care System, Durham, NC, USA. Electronic address: vishnukamal.golla@duke.edu.
² Department of Surgery, Division of Urology, Duke University Medical Center, Durham, NC, USA; Duke Cancer Institute, Durham, NC, USA; Duke-Margolis Policy Center.

PMID: 34776068
DOI: 10.1016/j.soc.2021.08.003

Abstract

Although integrated health care has largely been associated with increases in prices and static or decreased quality across many disease states, it has shown some successes in improving cancer care. However, its impact is largely equivocal, making consensus statements difficult. Critically, integration does not necessarily translate to clinical coordination, which might be the true driver behind the success of integrated health care delivery. Moving forward, it is important to establish payment models that support clinical care coordination. Shifting from a fragmented health system to a coordinated one may improve evidence-based cancer care, outcomes, and value for patients.

Keywords: Alternative payment models (APMs); Cancer care; Consolidation; Health delivery integration; Horizontal integration; Integrated delivery networks (IDNs); Value-based care; Vertical integration.

Publication types

Review

MeSH terms

Delivery of Health Care, Integrated*
Humans
Neoplasms* / therapy